Review of eprosartan: a new angiotensin II receptor antagonist. Summary.
Sica
D A
DA
Department of Clinical Pharmacology and Hypertension, Medical College of Virginia of Virginia Commonwealth University, Richmond 23298-1060, USA.
D000179:Acrylates / Q000378:metabolism / Q000493:pharmacokinetics / Q000494:pharmacology*; D057911:Angiotensin Receptor Antagonists; D000959:Antihypertensive Agents / Q000009:adverse effects / Q000493:pharmacokinetics / Q000494:pharmacology*; D006801:Humans; D007093:Imidazoles / Q000378:metabolism / Q000493:pharmacokinetics / Q000494:pharmacology*; D007668:Kidney / Q000098:blood supply / Q000187:drug effects; D012079:Renal Circulation / Q000187:drug effects; D013876:Thiophenes
D000179:Acrylates; D057911:Angiotensin Receptor Antagonists; D000959:Antihypertensive Agents; D007093:Imidazoles; D013876:Thiophenes; C068373:eprosartan